Poor-quality patient drug information has been identified as a major cause of preventable medication errors in the United States. The US Food and Drug Administration (FDA) has the authority to require marketing authorization holders of medicinal products to implement risk evaluation and mitigation strategies (REMS) to ensure that the benefits of a drug or biological product outweigh its risks. Aside from medication guides, no research has been conducted to assess the quality of patient-targeted REMS materials, including whether, and to what extent, patients find these materials understandable and actionable.
| INTRODUCTION
Providing health and safety information that is "accurate, accessible and actionable" is a stated objective of the US Department of Health and Human Services' National Action Plan to Improve Health Literacy. 1, 2 Nowhere, arguably, is this objective more critical than in the context of prescription medication information. Indeed, poor-quality patient drug information-that is, material that is written at too high a reading level is poorly designed and overly complicated-has been identified as a major cause of preventable medication errors in the United States. 3, 4 The importance of high-quality prescription drug information is further underscored by the fact that an estimated 80 million adults in America have limited health literacy. 5 Health literacy status is strongly associated with an individual's ability to read, understand, and interpret written drug information and to perform medication safe use practices, all critical elements in assisting them to safely and appropriately use their prescription drugs. [6] [7] [8] [9] [10] [11] While patients in the United States can receive information regarding their prescription drugs in a variety of ways, the main approved source is via the product label, including patient package inserts and medication guides (MGs). 12 Beyond the product label, patients can also receive educational materials developed under the aegis of a risk evaluation and mitigation strategy (REMS), a type of drug safety program that the United States Food and Drug Administration (FDA) can impose on drug marketing authorization holders to ensure that the benefits of a drug or biological product outweigh its risks. [13] [14] [15] Risk evaluation and mitigation strategy programs are designed to prevent or minimize the likelihood of occurrence of certain serious product-related risks (eg, teratogenicity and posterior multifocal leukoencephalopathy). If FDA determines that a REMS is necessary, the agency may require one or more REMS elements.
Such elements can include a MG, a patient package insert, a communication plan, or elements to assure safe use. The latter represents the most complex type of REMS programs and may include one or more of the following components: health care provider training and/or certification, documentation of safe use conditions, restrictions on product distribution, patient monitoring, or a patient registry. 14, 15 The purpose of risk evaluation and mitigation strategy patient materials (RPMs) is to convey information regarding specific drug risks associated with the use of the medication, symptoms to watch for, and safe drug-use practices that the patient should follow in order to minimize the likelihood that the risk(s) will occur. To date, Counseling tools for healthcare providers were also not included because these materials are directed towards prescribers. 23 We assessed key features of these RPMs, including their length, readability level, understandability, and actionability; all factors shown to affect the complexity, and hence, effectiveness of patient health information. 24 
| METHODS
RPMs were identified via a review of the FDA's rems@fda.gov, a publicly available, FDA-sponsored website, which provides the most definitive source of information regarding currently approved REMS programs. The website provides access to descriptions of the REMS programs as well as electronic copies of the approved REMS tools.
In March 2017, 2 reviewers (H.W.C. and M.Y.S.) reviewed each of REMS programs on the FDA website to identify REMS patient materials. All types of REMS were included in the review, with the exception of MG only REMS. Figure 1 describes the total number of REMS programs included in the analysis and those that were excluded.
| Reading level analysis
Readability is a quantitative estimate of reading difficulty as measured by word and sentence difficulty. The reading level of each of the RPMs was assessing using 3 validated readability tools: The Lexile Measure, the Gunning Fogg Index, and the Flesch Kincaid. [25] [26] [27] While each of these readability assessments are formulated differently, all examine the number of words per sentence and syllables per word.
As there is no gold standard for readability assessments, and each measure has its own limitations, we took the average of these 3
KEY POINTS
• The goal of REMS patient materials (RPMs) is to communicate specific drug risks and safe drug-use practices that the patient should follow in order to minimize the likelihood that the risk(s) will occur.
• While most (89%) of these RPMs met established PEMAT criteria for being understandable, less than half (49%) were deemed actionable. The median readability score for these materials was at a ninth-grade reading level or higher.
• Current approved RPMs can be improved by improving both their readability and actionability.
commonly used measures to obtain a more robust estimate of readability level. This approach has been used in the literature evaluating readability of written health materials. 28, 29 To prepare the text for analysis, portable document format of the written information was converted into word and text files. Many of the materials assessed included nontraditional text such as headings and bulleted phrases.
As measures of reading level often include sentence length (number of words between periods) as one of the components in the score calculation, periods were inserted after each heading and at the end of each bulleted phrase to ensure that they would be treated as short sentences in the analysis. In addition, drug names were removed from the materials in the analysis as the repetition of drug names can inflate the reading level.
Lexile scores were calculated using the Lexile Analyzer, which assigns a score to each document. 25 Scores range from 0 to 2000, and each score corresponds to student grade-level reading norms. 
| Understandability and actionability analysis
The understandability and actionability of the RPMs were assessed using the Patient Education Materials Assessment Tools (PEMAT), a psychometrically validated instrument developed specifically for patient-targeted educational materials. 32 Understandability refers to how well a text can be interpreted by consumers from all backgrounds. It includes text difficulty, formatting, organization, and the quality or clarity of the messages being communicated. Actionability refers to the degree to which the reader knows how to act on the messages being communicated. The PEMAT has 2 versions: one for print and a second for audiovisual materials. The version for print materials (PEMAT-P) consists of 24 items on 2 domains: understandability (17 items representing 6 topics) and actionability (7 items). According to the PEMAT instructions, each scale item is scored as either "Disagree" (0 points) or "Agree" (1 point), unless the item is deemed to be "not applicable" (N/A), in which case it is left unscored.
All scale points are then summed and divided by the number of scored items for each scale (excluding the items that were scored N/A) and this value is then converted into a percentage. The calculation of the total possible percentage point excludes the items that were scored as N/A both in the numerator and denominator; therefore, items scored as N/A do not lower the overall scores for the understandability and actionability scales. The total score for each scale can range between 0% and 100%, with a higher percentage indicating that the material has higher understandability and/or actionability. For example, a material that received an understandability score of 90% would be deemed to be more understandable than a material that received an understandability score of 60%. A score of 70% or below is the threshold for determining whether a material is poorly understandable or actionable. 29 
| Readability
The median readability score corresponded to a 9th-grade reading level (interquartile range, 8-10; range, 6-13). Two-thirds of REMS patient materials (67%) were assessed to be at a 9th-grade reading level or higher. Three of the 27 REMS patient materials (11%) attained a readability score of 12th grade or above. Figure 2 shows percent distribution of median readability scores for REMS patient materials by grade level.
| Understandability
The summary of understandability of the patient materials is provided in Table 2 . Figure 3 shows the distribution of PEMAT understandability and actionability scores for RPMs.
| Content
Seventeen of the 27 RPMs (63%) made their purpose completely evident. All of the RPMs avoided including information or content that distracted from the material's purpose.
| Word choice and style
All RPMs used common, everyday language and the active voice.
However, 3 RPMs (11%) used medical terms that were not defined in such a way as to be easily comprehensible for patients, (eg, homozygous familial hypercholesterolemia, heterozygous familial hypercholesterolemia, pulmonary oil microembolism, and meningococcal infections).
| Use of numbers
Nineteen of the RPMs (70%) included no numbers or statistical information of any kind. When numbers were used, 6 of 8 RPMs (75%) had numbers appearing in the material in clear and easy way to understand. None of the RPMs required the user to perform calculations.
| Organization
Twenty-five of the RPMs (93%) "chunked" information in short sections and included informative headers. Similarly, the majority of RPMs (93%) presented information in a logical sequence. Four of the RPMs do not require a summary because these materials were very short. Of the remaining 22 RPMs, the majority (67%) lacked a summary. Overall, the median understandability score was 85% (interquartile range, 74%-88%; range, 62%-90%). Twenty-four of the 27 RPMs (89%) met or exceeded the 70% threshold for understandability. Figure 4 shows percentage of RPMs with understandability and actionability scores falling above or below the acceptance threshold of 70%.
| Layout and design

| Actionability
All RPMs clearly identified at least 1 action the user could take, 26 of 27 addressed the reader directly when describing actions (96%), and 25 of 28 broke actions down into manageable, explicit steps (93%).
Only 13 of 27 materials (48%) provide a tangible tool such as checklist or diagrams to take action. Visual aids were rarely used (5 of 27, 19%) to make it easier to act on the instructions.
Overall, the median actionability score was 64% (interquartile range, 60%-83%; range, 20%-90%). Thirteen of the 27 REMS patient materials (48%) met or exceeded the 70% threshold for actionability. Table 3 shows aggregate score of RPMs based on individual PEMAT-P items.
| Interrater reliability of the PEMAT
Interrater reliability was substantial (κ = 0.73).
| DISCUSSION
This study sought to assess the quality of currently approved REMS educational materials for patients. Specifically, we assessed the readability, understandability, and actionability of these materials using well-validated, state-of-the-art instruments. To our knowledge, this is the first study of its kind to do so. Our study results add to the existing literature examining the quality and effectiveness of other types of patient education materials. 35, 36 Consistent with these other studies, our results highlighted important shortcomings in the quality of these materials. Specifically, while we found that the majority of patient-targeted REMS materials were meeting recommended standards in terms of understandability (89% met or exceeded the 70% threshold for understandability), they failed to do so in terms of readability and actionability. 9. The material's sections have informative headers. 25 (93) 0 (0) 2 (7) 10. The material presents information in a logical sequence. 27 (100) 0 (0) 0 (0) 11. The material provides a summary. Increasing readability typically leads to improvements in understanding. 37 However, our data indicated that patient education materials with higher grade-level readability could still be understandable.
Readability score is a quantitative estimate of reading difficulty measured by word and sentence complexity. Using individual words and sentences that are easy for patients to read is a necessary but not sufficient condition for ensuring that they can understand and use educational materials. 38, 39 Understandability is a broader and more qualitative construct that encompasses the content of the material, word choice and style, use of numbers, organization, layout and design, and incorporation of visual aids. For individuals with low literacy, visual design and appeal are particularly important 40 and increase the likelihood that the health information will be read. 41 definitions should be provided. 43 Summaries and visual aids can also enhance the understandability of these materials and increase the likelihood that they are consistent with best practice recommendations. 44 These recommendations are supported by previous research that has shown that patients, when confronted with multiple types of prescription drug information, can become confused or overwhelmed and, as a result, may not read any of the provided materials. 45, 46 Further, limiting information to only serious and actionable risks has been shown to improve overall risk recall and recognition. 47 Simple representations of risks in REMS materials can also help health care providers communicate safety information to patients more effectively and, potentially, may make REMS consultations more efficient. 48 Lastly, while most of the RPMs in this study omitted numeric and statistical information of any kind, presenting data using absolute risk and frequencies has been shown to improve the accuracy of interpretation by patients. [49] [50] [51] Several limitations of this research are worth noting. First, reading level measures are designed for use with text that is formatted traditionally, such as books, or newspaper and journal articles. As a result, existing readability instruments are unable to accommodate nontraditional text (e.g., nonsentences such as headings and bullets) such as was commonly found in the RPMs we reviewed. The appropriate method in readability determination is to include nonsentences in the analysis. Since bullet points and headings usually consist of a few words, analyzing the text without modifying nonsentences may artificially lower the readability scores. 52 Second, the 70% cutoff for the PEMAT scale scores for understandability and actionability has limited empirical basis. 32 We are not aware on any consensus of any standardize acceptable scores for PEMAT. Third, there are other aspects of good design for print materials, such as the inclusion of color, the use of 11 point serif font type, and tailoring information to reflect key characteristics of the reader, which were not systematically assessed in this analysis. 53 
| CONCLUSIONS
In conclusion, while most REMS educational materials for patients were found to be understandable, they had important shortcomings in regard to their readability and actionability. When patients receive well-designed drug safety information, they are more likely to read it, remember it, and act on it. Higher quality drug safety information for patients benefits everyone including patient with low health literacy. Specifically, patients benefit in terms of improved personal safety when using medicines, and the healthcare system and society as a whole benefit in terms of lower drug-related mortality and morbidity, and reduced healthcare utilization and associated costs. Incorporating best practice standards into the development of patient-targeted drug safety information, such as described in this study, represents a practical and highly feasible approach to improving the quality of these important educational materials.
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